Omalizumab Dose Step-Up and Treatment Response in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results from the OPTIMA Study. J of Skin. 2018;2(S1):S52. doi:10.25251/skin.2.supp.52